IRMD R&D to Revenue

Iradimed Corp · R&D to Revenue

IRMD logo

IRMD R&D to Revenue

Latest reported3.55%
IRMD FY R&D/Revenue (8.51% → 3.55%)
High-resolution chart · PNG

IRMD r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Iradimed Corp R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
3.5495%
3.8661%
4.3602%
4.2738%
4.5559%
5.9984%
3.7197%
4.9841%
7.4629%
4.1466%
5.5844%
6.8273%
8.9053%
8.5109%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.